The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Molecular mechanisms underlying ErbB2/HER2 action in breast cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760 · cited 1×
“%) in comedo forms of Ductal Carcinoma in situ (DCIS), a malignant ductal carcinoma that has not progressed beyond the basement membrane barrier (Barnes et al., 1992; Slamon et al., 1987; van de Vijver et al., 1988).”
BackgroundWAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862 · cited 1×
“Aberrant overexpression of D-type cyclins can reduce or overcome the dependency of mitogenic stimulation for a cell, and thus can play a role in the process of oncogenic transformation (reviewed in Bartkova et al., 1997; Sherr and Roberts, 1999; Weinberg, 1995).”
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
Clynes, R. A., Towers, T. L., Presta, L. G., & Ravetch, J. V. (2000) · Nature Medicine · doi:10.1038/74704 · Cited by 2,768 · cited 1×
“However, e ects mediated by the Fc portion of these antibodies also contribute to their tumorarresting activity (Clynes et al., 2000).”
BackgroundUllrich, A., Coussens, L., Hayflick, J. S., Dull, T. J., Gray, A., Tam, A. W., Lee, J., Yarden, Y., Libermann, T. A., Schlessinger, J., et al. (1984) · Nature · doi:10.1038/309418a0 · Cited by 2,752
Self-citationHunter, T. (2000) · Cell · doi:10.1016/s0092-8674(00)81688-8 · Cited by 2,586
Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
Toyoshima, H., & Hunter, T. (1994) · Cell · doi:10.1016/0092-8674(94)90573-8 · Cited by 2,043
Polyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., & Koff, A. (1994) · Genes & Development · doi:10.1101/gad.8.1.9 · Cited by 1,954
Graus-Porta, D. (1997) · The EMBO Journal · doi:10.1093/emboj/16.7.1647 · Cited by 1,590
Prenzel, N., Zwick, E., Daub, H., Leserer, M., Abraham, R., Wallasch, C., & Ullrich, A. (1999) · Nature · doi:10.1038/47260 · Cited by 1,504
Growth factor signaling by receptor tyrosine kinases
Schlessinger, J., & Ullrich, A. (1992) · Neuron · doi:10.1016/0896-6273(92)90177-f · Cited by 1,430
New functional activities for the p21 family of CDK inhibitors.
LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A., & Harlow, E. (1997) · Genes & Development · doi:10.1101/gad.11.7.847 · Cited by 1,402
Baselga, J., Tripathy, D., Mendelsohn, J., Baughman, S., Benz, C. C., Dantis, L., Sklarin, N. T., Seidman, A. D., Hudis, C. A., Moore, J., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.3.737 · Cited by 1,380
Requirement for neuregulin receptor erbB2 in neural and cardiac development
Lee, K.-F., Simon, H., Chen, H., Bates, B., Hung, M.-C., & Hauser, C. (1995) · Nature · doi:10.1038/378394a0 · Cited by 1,290
Multiple essential functions of neuregulin in development
Meyer, D., & Birchmeier, C. (1995) · Nature · doi:10.1038/378386a0 · Cited by 1,262
Targeted Disruption of Mouse EGF receptor: Effect of Genetic Background on Mutant Phenotype
Threadgill, D. W., Dlugosz, A. A., Hansen, L. A., Tennenbaum, T., Lichti, U., Yee, D., LaMantia, C., Mourton, T., Herrup, K., Harris, R. C., et al. (1995) · Science · doi:10.1126/science.7618084 · Cited by 1,179
The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen
Schechter, A. L., Stern, D. F., Vaidyanathan, L., Decker, S. J., Drebin, J. A., Greene, M. I., & Weinberg, R. A. (1984) · Nature · doi:10.1038/312513a0 · Cited by 1,175
Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor
Gassmann, M., Casagranda, F., Orioli, D., Simon, H., Lai, C., Klein, R., & Lemke, G. (1995) · Nature · doi:10.1038/378390a0 · Cited by 1,148
Cheng, M., Olivier, P., Diehl, J. A., Fero, M., Roussel, M. F., Roberts, J. M., & Sherr, C. J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1571 · Cited by 1,142 · cited 2×
“Under physiological conditions, it seems that p21Waf1 and p27Kip1, which can act as inhibitors of cyclin E- and A-dependent kinases, also act to positively regulate cyclin D-dependent kinases (Cheng et al., 1999; Polyak et al., 1994; Toyoshima and Hunter, 1994).”
BackgroundTzahar, E., Waterman, H., Chen, X., Levkowitz, G., Karunagaran, D., Lavi, S., Ratzkin, B. J., & Yarden, Y. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.10.5276 · Cited by 1,036
Self-citationCyclin D1 provides a link between development and oncogenesis in the retina and breast
Sicinski, P., Donaher, J. L., Parker, S. B., Li, T., Fazeli, A., Gardner, H., Haslam, S. Z., Bronson, R. T., Elledge, S. J., & Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90034-9 · Cited by 1,021
erb B-2 Is a Potent Oncogene When Overexpressed in NIH/3T3 Cells
Di Fiore, P. P., Pierce, J. H., Kraus, M. H., Segatto, O., King, C. R., & Aaronson, S. A. (1987) · Science · doi:10.1126/science.2885917 · Cited by 1,010
Strain-Dependent Epithelial Defects in Mice Lacking the EGF Receptor
Sibilia, M., & Wagner, E. F. (1995) · Science · doi:10.1126/science.7618085 · Cited by 1,002
Levkowitz, G., Waterman, H., Ettenberg, S. A., Katz, M., Tsygankov, A. Y., Alroy, I., Lavi, S., Iwai, K., Reiss, Y., Ciechanover, A., et al. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80231-2 · Cited by 1,001
Self-citationThe biology of erbB-2/nue/HER-2 and its role in cancer
Hynes, N. (1994) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(94)90012-4 · Cited by 971
c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor
Levkowitz, G., Waterman, H., Zamir, E., Kam, Z., Oved, S., Langdon, W. Y., Beguinot, L., Geiger, B., & Yarden, Y. (1998) · Genes & Development · doi:10.1101/gad.12.23.3663 · Cited by 865
Self-citationNeu-Protein Overexpression in Breast Cancer
van de Vijver, M. J., Peterse, J. L., Mooi, W. J., Wisman, P., Lomans, J., Dalesio, O., & Nusse, R. (1988) · New England Journal of Medicine · doi:10.1056/nejm198811103191902 · Cited by 860
Transforming p21 Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions
Albanese, C., Johnson, J., Watanabe, G., Eklund, N., Vu, D., Arnold, A., & Pestell, R. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23589 · Cited by 803
Pinkas-Kramarski, R., Soussan, L., Waterman, H., Levkowitz, G., Alroy, I., Klapper, L., Lavi, S., Seger, R., Ratzkin, B. J., Sela, M., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00603.x · Cited by 769
Self-citationSandgren, E. P., Luetteke, N. C., Palmiter, R. D., Brinster, R. L., & Lee, D. C. (1990) · Cell · doi:10.1016/0092-8674(90)90075-p · Cited by 752
Gillett, C., Fantl, V., Smith, D., Fisher, C., Bartek, J. J., Dickson, C., Barnes, D. M., & Peters, G. (1994) · PubMed · Cited by 750
Band Horwitz, S. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90048-b · Cited by 740
Mice lacking cyclin D1 are small and show defects in eye and mammary gland development.
Fantl, V, Stamp, G., Andrews, A., Rosewell, I., & Dickson, C. (1995) · Genes & Development · doi:10.1101/gad.9.19.2364 · Cited by 691
ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer.
Karunagaran, D., Tzahar, E., Beerli, R. R., Chen, X., Graus-Porta, D., Ratzkin, B. J., Seger, R., Hynes, N. E., & Yarden, Y. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00356.x · Cited by 674
Self-citationTranscriptional Regulation of the p21(WAF1/CIP1)Gene
Gartel, A. L., & Tyner, A. L. (1999) · Experimental Cell Research · doi:10.1006/excr.1998.4319 · Cited by 664
MEMBRANE-ANCHORED GROWTH FACTORS
Massagué, J., & Pandiella, A. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.002503 · Cited by 660
Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin.
Sliwkowski, M. X., Schaefer, G., Akita, R. W., Lofgren, J. A., Fitzpatrick, V. D., Nuijens, A., Fendly, B. M., Cerione, R. A., Vandlen, R. L., & Carraway, K. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36676-0 · Cited by 643
p21-containing cyclin kinases exist in both active and inactive states.
Zhang, H., Hannon, G. J., & Beach, D. (1994) · Genes & Development · doi:10.1101/gad.8.15.1750 · Cited by 632
Hudziak, R. M., Schlessinger, J., & Ullrich, A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7159 · Cited by 625
A neu acquaintance for ErbB3 and ErbB4: A role for receptor heterodimerization in growth signaling
Carraway, K. L., & Cantley, L. C. (1994) · Cell · doi:10.1016/0092-8674(94)90564-9 · Cited by 587
Mann, G. B., Fowler, K. J., Gabriel, A., Nice, E. C., Williams, R. L., & Dunn, A. R. (1993) · Cell · doi:10.1016/0092-8674(93)90227-h · Cited by 583
Luetteke, N. C., Qiu, T. H., Fssssenton, S. E., Troyer, K. L., Riedel, R. F., Chang, A., & Lee, D. C. (1999) · Development · doi:10.1242/dev.126.12.2739 · Cited by 567
Holland, E. C., Hively, W. P., DePinho, R. A., & Varmus, H. E. (1998) · Genes & Development · doi:10.1101/gad.12.23.3675 · Cited by 556
Biochemical and Clinical Implications of the ErbB/HER Signaling Network of Growth Factor Receptors
(1999) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60784-8 · Cited by 540
Cyclin D1 protein expression and function in human breast cancer
Bartkova, J., Lukas, J., Müller, H., Lützhøt, D., Strauss, M., & Bartek, J. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570311 · Cited by 509
Cheng, M., Sexl, V., Sherr, C. J., & Roussel, M. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.1091 · Cited by 496
Nosaka, T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.17.4754 · Cited by 491
Neuregulins and Their Receptors: A Versatile Signaling Module in Organogenesis and Oncogenesis
Burden, S., & Yarden, Y. (1997) · Neuron · doi:10.1016/s0896-6273(00)80324-4 · Cited by 476
Self-citationKlapper, L. N., Glathe, S., Vaisman, N., Hynes, N. E., Andrews, G. C., Sela, M., & Yarden, Y. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.4995 · Cited by 455
Self-citationAll ErbB Receptors Other Than the Epidermal Growth Factor Receptor Are Endocytosis Impaired
Baulida, J., Kraus, M. H., Alimandi, M., Fiore, P. P. D., & Carpenter, G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.9.5251 · Cited by 454
Lange, C. A., Shen, T., & Horwitz, K. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1032 · Cited by 450
Siegel, P. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.8.2149 · Cited by 442
The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase.
Luetteke, N. C., Phillips, H. K., Qiu, T. H., Copeland, N. G., Earp, H. S., Jenkins, N. A., & Lee, D. C. (1994) · Genes & Development · doi:10.1101/gad.8.4.399 · Cited by 441
A point mutation in the neu oncogene mimics ligand induction of receptor aggregation
Weiner, D. B., Liu, J., Cohen, J. A., Williams, W. V., & Greene, M. I. (1989) · Nature · doi:10.1038/339230a0 · Cited by 423
Carlomagno, C., Perrone, F., Gallo, C., De Laurentiis, M., Lauria, R., Morabito, A., Pettinato, G., Panico, L., D'Antonio, A., Bianco, A. R., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2702 · Cited by 407
Heregulin‐dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3.
Wallasch, C., Weiss, F. U., Niederfellner, G., Jallal, B., Issing, W., & Ullrich, A. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00101.x · Cited by 406
Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases
Carraway III, K. L., Weber, J. L., Unger, M. J., Ledesma, J., Yu, N., Gassmann, M., & Lai, C. (1997) · Nature · doi:10.1038/387512a0 · Cited by 394
Pietras, R. J., Pegram, M. D., Finn, R. S., Maneval, D. A., & Slamon, D. J. (1998) · Oncogene · doi:10.1038/sj.onc.1202132 · Cited by 386
Neuregulin-3 (NRG3): A novel neural tissue-enriched protein that binds and activates ErbB4
Zhang, D., Sliwkowski, M. X., Mark, M., Frantz, G., Akita, R., Sun, Y., Hillan, K., Crowley, C., Brush, J., & Godowski, P. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9562 · Cited by 383
Binding specificities and affinities of egf domains for ErbB receptors
Jones, J. T., Akita, R. W., & Sliwkowski, M. X. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00283-5 · Cited by 381
The Cellular Response to Neuregulins Is Governed by Complex Interactions of the erbB Receptor Family
Riese, D. J., van Raaij, T. M., Plowman, G. D., Andrews, G. C., & Stern, D. F. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5770 · Cited by 368
Intermolecular association of the p185 protein and EGF receptor modulates EGF receptor function
Wada, T., Qian, X., & Greene, M. I. (1990) · Cell · doi:10.1016/0092-8674(90)90697-d · Cited by 361
Prigent, S. A., & Gullick, W. J. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06577.x · Cited by 359
Pietras, R. J., Poen, J. C., Gallardo, D., Wongvipat, P. N., Lee, H. J., & Slamon, D. J. (1999) · PubMed · Cited by 353
Yu, D., Jing, T., Liu, B., Yao, J., Tan, M., McDonnell, T. J., & Hung, M.-C. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80157-4 · Cited by 353
Klapper, L. N., Waterman, H., Sela, M., & Yarden, Y. (2000) · PubMed · Cited by 351
Self-citationLee, R. J., Albanese, C., Fu, M., D'Amico, M., Lin, B., Watanabe, G., Haines, G. K., Siegel, P. M., Hung, M.-C., Yarden, Y., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.2.672-683.2000 · Cited by 347
Self-citationThe EGF receptor as central transducer of heterologous signalling systems
Zwick, E., Hackel, P. O., Prenzel, N., & Ullrich, A. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01373-5 · Cited by 343
Rescue of Cyclin D1 Deficiency by Knockin Cyclin E
Geng, Y., Whoriskey, W., Park, M. Y., Bronson, R. T., Medema, R. H., Li, T., Weinberg, R. A., & Sicinski, P. (1999) · Cell · doi:10.1016/s0092-8674(00)80788-6 · Cited by 336
Weinstat-Saslow, D., Merino, M. J., Manrow, R. E., Lawrence, J. A., Bluth, R. F., Wittenbel, K. D., Simpson, J. F., Page, D. L., & Steeg, P. S. (1995) · Nature Medicine · doi:10.1038/nm1295-1257 · Cited by 335
Sjögren, S., Inganäs, M., Lindgren, A., Holmberg, L., & Bergh, J. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.462 · Cited by 327
Worthylake, R., Opresko, L. K., & Wiley, H. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8865 · Cited by 325
Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase
Harari, D., Tzahar, E., Romano, J., Shelly, M., Pierce, J., Andrews, G., & Yarden, Y. (1999) · Oncogene · doi:10.1038/sj.onc.1202631 · Cited by 318
Self-citationSchweitzer, R., Shaharabany, M., Seger, R., & Shilo, B. Z. (1995) · Genes & Development · doi:10.1101/gad.9.12.1518 · Cited by 317 · cited 1×
“Proteolytic cleavage of the extracellular domain, resulting in release of the active EGF-like domain seems to be required for ligand activation (Loeb et al., 1998; Schweitzer et al., 1995).”
BackgroundKokai, Y., Myers, J. N., Wada, T., Brown, V. I., LeVea, C. M., Davis, J. G., Dobashi, K., & Greene, M. I. (1989) · Cell · doi:10.1016/0092-8674(89)90843-x · Cited by 309
Moscatello, D. K., Holgado-Madruga, M., Emlet, D. R., Montgomery, R. B., & Wong, A. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.200 · Cited by 305
Lane, H. A., Beuvink, I., Motoyama, A. B., Daly, J. M., Neve, R. M., & Hynes, N. E. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.9.3210-3223.2000 · Cited by 298
Graus-Porta, D., Beerli, R. R., & Hynes, N. E. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.3.1182 · Cited by 296
Ligands for ErbB-family receptors encoded by a neuregulin-like gene
Chang, H., Riese II, D. J., Gilbert, W., Stern, D. F., & McMahan, U. J. (1997) · Nature · doi:10.1038/387509a0 · Cited by 281
Employment of the Epidermal Growth Factor Receptor in Growth Factor–Independent Signaling Pathways
Carpenter, G. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.4.697 · Cited by 272
Estrogen-Dependent Cyclin E-cdk2 Activation through p21 Redistribution
Planas-Silva, M. D., & Weinberg, R. A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.4059 · Cited by 267
de Jong, J. S., van Diest, P. J., van der Valk, P., & Baak, J. P. A. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199801)184:1<53::aid-path6>3.0.co;2-7 · Cited by 257
Borg, Å., Baldetorp, B., Fernö, M., Killander, D., Olsson, H., Ryden, S., & Sigurdsson, H. (1994) · Cancer Letters · doi:10.1016/0304-3835(94)90194-5 · Cited by 246
Structural and functional aspects of the multiplicity of Neu differentiation factors.
Wen, D., Suggs, S. V., Karunagaran, D., Liu, N., Cupples, R. L., Luo, Y., Janssen, A. M., Ben-Baruch, N., Trollinger, D. B., & Jacobsen, V. L. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1909 · Cited by 234
Expression of the ERBB3 gene product in breast cancer
Lemoine, N., Barnes, D., Hollywood, D., Hughes, C., Smith, P., Dublin, E., Prigent, S., Gullick, W., & Hurst, H. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.420 · Cited by 234
Peles, E., Ben-Levy, R., Tzahar, E., Liu, N., Wen, D., & Yarden, Y. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05737.x · Cited by 233
Self-citationHouston, S. J., Plunkett, T. A., Barnes, D. M., Smith, P., Rubens, R. D., & Miles, D. W. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690196 · Cited by 220
Fowler, K. J., Walker, F., Alexander, W., Hibbs, M. L., Nice, E. C., Bohmer, R. M., Mann, G. B., Thumwood, C., Maglitto, R., & Danks, J. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1465 · Cited by 216
Transformation of NIH 3T3 Cells by HER3 or HER4 Receptors Requires the Presence of HER1 or HER2
Zhang, K., Sun, J., Liu, N., Wen, D., Chang, D., Thomason, A., & Yoshinaga, S. K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.7.3884 · Cited by 207
Alternative Intracellular Routing of ErbB Receptors May Determine Signaling Potency
Waterman, H., Sabanai, I., Geiger, B., & Yarden, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13819 · Cited by 207
Self-citationConvergence of Progesterone and Epidermal Growth Factor Signaling in Breast Cancer
Lange, C. A., Richer, J. K., Shen, T., & Horwitz, K. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.31308 · Cited by 200
Ben-Levy, R., Paterson, H. F., Marshall, C. J., & Yarden, Y. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06632.x · Cited by 196
Self-citationNewby, J. C., Johnston, S. R. D., Smith, I. E., et al. (1997) · PubMed · Cited by 192
Expression of c-erbB3 protein in primary breast carcinomas
Naidu, R., Yadav, M., Nair, S., & Kutty, M. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.689 · Cited by 190
Effects of oncogenic ErbB2 on G1 cell cycle regulators in breast tumour cells
Neve, R. M., Sutterlüty, H., Pullen, N., Lane, H. A., Daly, J. M., Krek, W., & Hynes, N. E. (2000) · Oncogene · doi:10.1038/sj.onc.1203470 · Cited by 180
Tsai, C.-M., Chang, K.-T., Perng, R.-P., Mitsudomi, T., Chen, M.-H., Kadoyama, C., & Gazdar, A. F. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.11.897 · Cited by 175
Klapper, L. N., Vaisman, N., Hurwitz, E., Pinkas-Kramarski, R., Yarden, Y., & Sela, M. (1997) · Oncogene · doi:10.1038/sj.onc.1201029 · Cited by 174
Self-citationElenius, K., Choi, C. J., Paul, S., Santiestevan, E., Nishi, E., & Klagsbrun, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202612 · Cited by 170
Riese, D. J., Kim, E. D., Elenius, K., Buckley, S., Klagsbrun, M., Plowman, G. D., & Stern, D. F. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.33.20047 · Cited by 166
Nicholson, S., Richard, J., Sainsbury, C., Halcrow, P., Kelly, P., Angus, B., Wright, C., Henry, J., Farndon, Jr., & Harris, A. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.30 · Cited by 165
Monoclonal antibodies identify a cell-surface antigen associated with an activated cellular oncogene
Drebin, J. A., Stern, D. F., Link, V. C., Weinberg, R. A., & Greene, M. I. (1984) · Nature · doi:10.1038/312545a0 · Cited by 163
Fox, S. B., Smith, K., Hollyer, J., Greenall, M., Hastrich, D., & Harris, A. L. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00666180 · Cited by 161
Nuclear expression of the c-erbB-4/HER-4 growth factor receptor in invasive breast cancers.
Srinivasan, R., Gillett, C., Barnes, D. M., & Gullick, W. J. (2000) · PubMed · Cited by 158
Intracellular expression of single chain antibodies reverts ErbB-2 transformation.
Beerli, R. R., Wels, W. S., & Hynes, N. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)51027-4 · Cited by 155
Aguilar, Z., Akita, R. W., Finn, R. S., Ramos, B. L., Pegram, M. D., Kabbinavar, F. F., Pietras, R. J., Pisacane, P. I., Sliwkowski, M. X., & Slamon, D. J. (1999) · Oncogene · doi:10.1038/sj.onc.1202993 · Cited by 155
Kasprzyk, P. G., Song, S. U., Fiore, P. P. D., & King, C. R. (1992) · PubMed · Cited by 151
Ye, D., Mendelsohn, J. M., & Fan, Z. (1999) · Oncogene · doi:10.1038/sj.onc.1202319 · Cited by 151
There Must Be 50 Ways to Rule the Signal: The Case of the Drosophila EGF Receptor
Perrimon, N., & Perkins, L. A. (1997) · Cell · doi:10.1016/s0092-8674(00)80177-4 · Cited by 149
sli-1, a negative regulator of let-23-mediated signaling in C. elegans.
Jongeward, G. D., Clandinin, T. R., & Sternberg, P. W. (1995) · Genetics · doi:10.1093/genetics/139.4.1553 · Cited by 149
Hurwitz, E., Stancovski, I., Sela, M., & Yarden, Y. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3353 · Cited by 148
Self-citationErbB Tyrosine Kinases and the Two Neuregulin Families Constitute a Ligand-Receptor Network
Pinkas‐Kramarski, R., Shelly, M., Guarino, B. C., Wang, L. M., Lyass, L., Alroy, I., Alamandi, M., Kuo, A. H., Moyer, J. D., Lavi, S., et al. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.10.6090 · Cited by 145
Self-citationAlimandi, M., Wang, L., Bottaro, D. P., Lee, C., Kuo, A. H., Frankel, M. E., Fedi, P., Tang, C. K., Lippman, M. E., & Pierce, J. H. (1997) · The EMBO Journal · doi:10.1093/emboj/16.18.5608 · Cited by 132
Hudziak, R. M., Lewis, G. D., Shalaby, M. R., Eessalu, T. E., Aggarwal, B. B., Ullrich, A., & Shepard, H. M. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5102 · Cited by 132
Pinkas‐Kramarski, R., Eilam, R., Alroy, I., Levkowitz, G., Lonai, P., & Yarden, Y. (1997) · Oncogene · doi:10.1038/sj.onc.1201466 · Cited by 130
Self-citationFan, Z., Lu, Y., Wu, X., DeBlasio, A., Koff, A., & Mendelsohn, J. M. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.131.1.235 · Cited by 129
Knowlden, J. M., Gee, J. M. W., Seery, L. T., Farrow, L., Gullick, W. J., Ellis, I. O., Blamey, R. W., Robertson, J. F. R., & Nicholson, R. I. (1998) · Oncogene · doi:10.1038/sj.onc.1202107 · Cited by 129
Yu, D., Liu, B., Jing, T., Sun, D., Price, J. E., Singletary, S. E., Ibrahim, N., Hortobágyi, G. N., & Hung, M. (1998) · Oncogene · doi:10.1038/sj.onc.1201729 · Cited by 127
Cohen, B. D., Kiener, P. A., Green, J. M., Foy, L., Fell, H. P., & Zhang, K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.48.30897 · Cited by 125
Tang, C. K., Pérez, C., Grunt, T. W., Waibel, C., Cho, C., & Lupu, R. (1996) · PubMed · Cited by 120
Daly, J. M., Jannot, C. B., Beerli, R. R., Graus-Porta, D., Maurer, F. G., & Hynes, N. E. (1997) · PubMed · Cited by 115
Newman, S. P., Bates, N. P., Vernimmen, D., Parker, M. G., & Hurst, H. C. (2000) · Oncogene · doi:10.1038/sj.onc.1203416 · Cited by 114
Epidermal growth factor-related peptides in the pathogenesis of human breast cancer
Normanno, N., Ciardiello, F., Brandt, R., & Salomon, D. S. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00666178 · Cited by 110
Overexpression of Cyclin D1 in Epithelial Ovarian Cancers
Worsley, S. D., Ponder, B. A. J., & Davies, B. R. (1997) · Gynecologic Oncology · doi:10.1006/gyno.1996.4569 · Cited by 106
Waterman, H., Alroy, I., Strano, S., Seger, R., & Yarden, Y. (1999) · The EMBO Journal · doi:10.1093/emboj/18.12.3348 · Cited by 103
Self-citationRiese, D. J., Komurasaki, T., Plowman, G. D., & Stern, D. F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.18.11288 · Cited by 102
Bacus, S. S., Stancovski, I., Huberman, E., Chin, D., Hurwitz, E., Mills, G. B., Ullrich, A., Sela, M., & Yarden, Y. (1992) · PubMed · Cited by 101
Self-citationAberrations of the G1- and G1/S-regulating genes in human cancer
Bártková, J., Lukas, J., & Bártek, J. (1997) · Springer eBooks · doi:10.1007/978-1-4615-5371-7_16 · Cited by 100
Wang, L.-M., Kuo, A. H., Alimandi, M., Veri, M. C., Lee, C.-C., Kapoor, V., Ellmore, N., Chen, X.-H., & Pierce, J. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6809 · Cited by 99
Pinkas‐Kramarski, R., Lenferink, A. E. G., Bacus, S. S., Lyass, L., van de Poll, M. L. M., Klapper, L. N., Tzahar, E., Sela, M., van Zoelen, E. J. J., & Yarden, Y. (1998) · Oncogene · doi:10.1038/sj.onc.1201642 · Cited by 99
Self-citationThe Structural Basis for the Specificity of Epidermal Growth Factor and Heregulin Binding
Barbacci-Tobin, E. G., Guarino, B. C., Stroh, J. G., Singleton, D. H., Rosnack, K. J., Moyer, J. D., & Andrews, G. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.16.9585 · Cited by 95
Differential Sensitivity to Static Visual Cues in the Control of Postural Equilibrium in Man
Crémeux, J., & Mesure, S. (1994) · Perceptual and Motor Skills · doi:10.2466/pms.1994.78.1.67 · Cited by 95
Fan, Z., Shang, B. Y., Lü, Y., Chou, J. L., & Mendelsohn, J. M. (1997) · PubMed · Cited by 93
17 beta-estradiol mimics ligand activity of the c-erbB2 protooncogene product.
Matsuda, S., Kadowaki, Y., Ichino, M., Akiyama, T., Toyoshima, K., & Yamamoto, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10803 · Cited by 92
Neu Differentiation Factor Stimulates Phosphorylation and Activation of the Sp1 Transcription Factor
Alroy, I., Soussan, L., Seger, R., & Yarden, Y. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1961 · Cited by 90
Self-citationPeles, E., Lamprecht, R., Ben-Levy, R., Tzahar, E., & Yarden, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49834-7 · Cited by 87
Self-citationBacus, S. S., Chin, D., Yarden, Y., Zelnick, C. R., & Stern, D. F. (1996) · Europe PMC (PubMed Central) · Cited by 85
Self-citationCrovello, C. S., Lai, C., Cantley, L. C., & Carraway, K. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26954 · Cited by 85
HER4-mediated Biological and Biochemical Properties in NIH 3T3 Cells
Cohen, B. D., Green, J. M., Foy, L., & Fell, H. P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.9.4813 · Cited by 81
Gjoerup, O. V., Lukas, J., Bártek, J., & Willumsen, B. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18812 · Cited by 81
Mack, L. A., Kerkvliet, N. I., Doig, G. S., & O’Malley, F. P. (1997) · Human Pathology · doi:10.1016/s0046-8177(97)90014-9 · Cited by 77
O’Rourke, D. M., Kao, G. D., Singh, N., Park, B., Muschel, R. J., Wu, C.-J., & Greene, M. I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10842 · Cited by 76
Ras induces p21Cip1/Waf1 cyclin kinase inhibitor transcriptionally through Sp1-binding sites
Kivinen, L., Tsubari, M., Haapajärvi, T., Datto, M., Wang, X.-F., & Laiho, M. (1999) · Oncogene · doi:10.1038/sj.onc.1203000 · Cited by 76
Grunt, T. W., Saceda, M., Martin, M. B., Lupu, R., Dittrich, E., Krupitza, G., Harant, H., Huber, H. P., & Dittrich, C. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910630417 · Cited by 72
Heregulin Regulation of Akt/Protein Kinase B in Breast Cancer Cells
Liu, W., Li, J., & Roth, R. A. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1144 · Cited by 70
HER-2/neu Is Rate-limiting for Ovarian Cancer Growth
Juhl, H. H., Downing, S. G., Wellstein, A., & Czubayko, F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.47.29482 · Cited by 70
Loeb, J. A., Susanto, E. T., & Fischbach, G. D. (1998) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1998.0676 · Cited by 67
Fiddes, R. J., Janes, P. W., Sivertsen, S., Sutherland, R. L., Musgrove, E. A., & Daly, R. J. (1998) · Oncogene · doi:10.1038/sj.onc.1201815 · Cited by 66
A role for E2F1 in Ras activation of p21(WAF1/CIP1) transcription
Gartel, A. L., Najmabadi, F., Goufman, E., & Tyner, A. L. (2000) · Oncogene · doi:10.1038/sj.onc.1203411 · Cited by 57
c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients
Placido, S. D., Carlomagno, C., Laurentiis, M. D., et al. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006159001039 · Cited by 55
Aziz, N. A., Cherwinski, H. M., & McMahon, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1101 · Cited by 55
Ben-Levy, R., Peles, E., Goldman-Michael, R., & Yarden, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41926-6 · Cited by 50
Self-citationTorregrosa, D., Bolufer, P., Lluch, A. M., López, J. A., Barragán, E., Ruíz, A., Guillém, V., Munárriz, B., & Conde, J. G. (1997) · Clinica Chimica Acta · doi:10.1016/s0009-8981(97)06542-x · Cited by 46
Vogt, U., Bielawski, K. P., Schlotter, C. M., Bosse, U., Falkiewicz, B., & Podhajska, A. J. (1998) · Gene · doi:10.1016/s0378-1119(98)00454-5 · Cited by 44
van Agthoven, T., Timmermans, M. A. M., Dorssers, L. C. J., & Henzen-Logmans, S. C. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910630607 · Cited by 44
Biochemical characterization of mutant EGF receptors expressed in the hemopoietic cell line BaF/3
Walker, F., Hibbs, M. L., Zhang, H., et al. (1998) · Growth Factors · doi:10.3109/08977199809017491 · Cited by 36
Flanagan, J. G., & Leder, P. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.21.8057 · Cited by 15
Cited by
Blume-Jensen, P., & Hunter, T. (2001) · Nature · doi:10.1038/35077225 · Cited by 3,738
PI3K/Akt signalling pathway and cancer
Vara, J. Á. F., Casado, E., de Castro, J., Cejas, P., Belda-Iniesta, C., & González-Barón, M. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2003.07.007 · Cited by 2,443
New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging
Kobayashi, H., Ogawa, M., Alford, R., Choyke, P. L., & Urano, Y. (2010) · Chemical Reviews · doi:10.1021/cr900263j · Cited by 2,200
The protein kinase B/Akt signalling pathway in human malignancy
Nicholson, K. M., & Anderson, N. G. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00271-6 · Cited by 1,639
Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab
Cho, H.-S., Mason, K., Ramyar, K. X., Stanley, A. M., Gabelli, S. B., Denney, D. W., & Leahy, D. J. (2003) · Nature · doi:10.1038/nature01392 · Cited by 1,612
Metadata
- Authors
- Harari, D., & Yarden, Y.
- Venue
- Oncogene
- Published
- 2000-12-09
- Volume
- 19
- Issue
- 53
- Pages
- 6102-6114
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1967647822
- Cited by
- 633
- References
- 160
- FWCI
- 12.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.